达帕格利弗洛辛对糖尿病眼部并发症的影响:一项观察性队列研究
Jo-Hsin Chen1, Fei-Hung Hung2, Yu-Ting Wang1
1Department of Pharmacy, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
概括
达帕格利弗洛辛显著降低了2型糖尿病患者糖尿病视网膜病变,开角玻璃眼和视力损失的风险. 这种SGLT2抑制剂在预防严重的眼部并发症方面表现有前途.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 带来眼部并发症的风险,如糖尿病视网膜病变 (DR) 和开角玻璃眼 (OAG).
- 糖共运输体2抑制剂 (SGLT2i),如达帕格利弗洛辛,用于管理T2DM.
- 在T2DM患者中SGLT2i的眼睛安全性需要进一步调查.
研究的目的:
- 为了评估T2DM患者用达帕格利弗洛辛治疗的眼部结局 (DR,OAG,视力损失) 的发生率,与其他低血糖药物相比.
- 评估T2DM患者开始达帕格利弗洛辛治疗的严重眼睛疾病的比较风险.
主要方法:
- 使用台北医科大学临床研究数据库进行的观察性,回顾性,多中心队列研究 (2016-2020年).
- 从18854名新诊断的T2DM患者中,1400名达帕格利弗洛辛使用者和1400名非SGLT2i使用者的倾向性得分匹配 (1:1).
- 主要结局:在1年和2年的随访期间,DR,OAG或视力损失的复合发病率.
主要成果:
- 达帕格利弗洛辛的使用者在1年内显著降低了DR,OAG或视力损失的复合发病率 (2.78%对5.35%;aHR=0.53,p=0.002).
- 这种减少的发病率持续了2年 (3.85%对6.35%;aHR=0.63,p=0.007).
结论:
- 达帕格利弗洛辛与T2DM患者主要眼部并发症的发生率显著降低有关.
- 这些发现表明,达帕格利弗洛辛可能对DR,OAG和视力损失提供保护性益处.
- 这凸显了达帕格利弗洛辛在T2DM眼部健康管理中的潜在作用.
相关概念视频
01:27Open Angle Glaucoma: Treatment
938
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
938
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
566
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
566
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
567
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
567
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K